Latest News & Analysis
markets
Market Index Performance | March 2026
Our monthly update detailing the short- and long-term performance of major indices.
personal-finance
Unconventional wisdom: Lessons from a century of returns
Sobering research shows how hard it is to find the right shares.
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
stocks
Revenue growth on track for undervalued ASX healthcare stock
Near-term cost growth does not change our long-term view.
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
markets
Analysts: US-Iran ceasefire won’t mean a quick return to market normalcy
Oil prices are seen remaining elevated, with market volatility likely continuing.
retirement
Key changes to 2026/27 super thresholds
Stay on top of the latest changes to superannuation rates and thresholds for 2026, including increases to transfer balance cap, concessional contributions cap, and non-concessional contributions cap.
etfs
ETF Spotlight: Seeking growth beyond the US market
Revisiting where the next leg of global growth may come from.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
personal-finance
The ATO has released a super health check – here’s what I would have told you instead
The ATO recently came out with a ‘super health check’. Here’s what I would’ve put into it.
personal-finance
How much you need to invest if you started late
In this episode of Investing Compass, Mark and Shani look at how you can make up for lost years.
personal-finance
One risk after another
Investors often focus on front-of-mind risks, reacting to each headline event without considering long-term impacts.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
etfs
Young & Invested: What we think about the biggest ETFs on the ASX
The latest insights on popular picks from our Morningstar analysts.
markets
Market Minute: Conflicting messages mean ups and downs
Iran is still a focus, with mixed messages from the U.S. government. Plus, what do 100% tariffs mean for Australian pharmaceuticals?
of 665
Viewing 1 to 16 of 10637